Organigram Partners with Avida Medical for UK Market Expansion
The TDR Three Key Takeaways regarding Organigram Holdings and Avida Medical:
- Organigram Holdings collaborates with Avida Medical to expand its reach in the UK market.
- Earlier this year Organigram has also invested in Open Book Extracts
- Organigram Holdings’ UK expansion is seen as crucial for medical cannabis access.
Organigram Holdings Inc. (NasdaqGS:OGI) has announced a partnership with Avida Medical to expand its presence in the UK market, reflecting the growing demand for medical cannabis. Tim Emberg, Chief Commercial Officer of Organigram, stated, “We are pleased to partner with Avida Medical in the UK, marking yet another exciting milestone for Organigram’s expansion into the global market.” Avida Medical’s CEO, Paul Parkinson, highlighted the collaboration’s importance, noting, “Our agreement with Organigram exemplifies our commitment to providing the highest quality medicine and service to patients.”
In addition to this strategic UK expansion, Organigram is also strengthening its presence in the U.S. market. This year the company has also invested in Open Book Extracts, a North Carolina-based hemp derivatives company, aiming to leverage the growing U.S. hemp market. To support this and other growth initiatives, the company announced a public offering to raise approximately CAD 25 million.
Organigram’s expertise in cannabis cultivation and production positions it well to cater to the UK’s growing market needs. Emberg added, “With our extensive industry expertise in cultivation and production, we are poised to elevate accessibility and cater to the evolving requirements of patients in the UK.”
This partnership aims to capitalize on the UK’s growing cannabis industry, which is expected to grow substantially. Parkinson emphasized, “This is a hugely positive collaboration for Avida Medical and brings us a step closer to becoming one of the pre-eminent manufacturers of medicinal cannabis products here in the UK.”
Organigram’s partnership with Avida Medical underscores the potential of the UK market and the importance of strategic collaborations in the cannabis industry. This partnership is likely to have a big impact on the accessibility and medical cannabis in the UK. Want to be updated on all things Psychedelic, Cannabis, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!
